Chapter
Microdosing Psychedelics for Depression: Potential or Risks?
1:50:21 - 1:57:06 (06:44)
The potential effects of microdosing are not as significant as high-dose psilocybin in treating depression or addiction. However, there could be some negative effects in the long run, so it's important to weigh the potential benefits against the risks.
Clips
Joe Rogan and Ethan Nadelmann discuss the potential benefits and pitfalls of microdosing psychedelics to treat depression and addiction, and evaluate its effectiveness in comparison to higher doses of psilocybin.
1:50:21 - 1:54:43 (04:21)
Summary
Joe Rogan and Ethan Nadelmann discuss the potential benefits and pitfalls of microdosing psychedelics to treat depression and addiction, and evaluate its effectiveness in comparison to higher doses of psilocybin.
ChapterMicrodosing Psychedelics for Depression: Potential or Risks?
EpisodeDr. Matthew Johnson: Psychedelics for Treating Mental Disorders
PodcastHuberman Lab
The potential cumulative negative effects of microdosing psychedelics through serotonin 5-HT2B receptor or other mechanisms require careful consideration for physical and psychological safety in the context of research, but there is low concern for toxicity or cardiotoxicity with therapeutic usage of psychedelics a few times in a lifetime.
1:54:43 - 1:57:06 (02:23)
Summary
The potential cumulative negative effects of microdosing psychedelics through serotonin 5-HT2B receptor or other mechanisms require careful consideration for physical and psychological safety in the context of research, but there is low concern for toxicity or cardiotoxicity with therapeutic usage of psychedelics a few times in a lifetime.